# Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma

> **NCT00946374** · PHASE2 · UNKNOWN · sponsor: **Heidelberg University** · enrollment: 20 (estimated)

## Conditions studied

- Mantle-Cell Lymphoma

## Interventions

- **DRUG:** Immunochemotherapy
- **DRUG:** High-dose BEAM plus autologous SCT
- **OTHER:** HLA-identical allogenic SCT

## Key facts

- **NCT ID:** NCT00946374
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-07
- **Primary completion:** 2010-12
- **Final completion:** 2011-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2009-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00946374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00946374, "Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00946374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*